Content
07/10/2017
St. Louis, MO USA
NewLeaf Symbiotics
completed $24 million Series C Round funding. Investors include
Open Prairie Ventures, Pangaea Ventures, RockPort Capital, Lewis & Clark Ventures.
About
NewLeaf Symbiotics is the industry’s undisputed Ag Biotech leader and pioneer of PPFM technology. The proud Champions of Pink Performance, NewLeaf works to harness pink-pigmented facultative methylotrophs – PPFMs – into actionable solutions to challenges around yield, crop protection, nutrient use efficiency and methane mitigation, with the intent of helping farmers do more with less as they work to feed a growing population.
Startup
Sector:
AgTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
